Trial :

Basal Cell Carcinomas (BCCs) Study

Age :

18 - 85 years

Scientia Clinical Research is collaborating with Feldan Therapeutics, a Canadian pharmaceutical company that is conducting a clinical trial in Australia for a new and novel intralesional potential treatment of basal cell carcinomas (BCCs).

We are currently seeking participants aged 18-85 years with a nodular BCC that has not been removed or previously treated.

Click here for more information or go to the website of the Australian New Zealand Clinical Trial Registry and search for clinical trials for basal cell carcinomas.

If you meet the criteria for this study and would like more information, register below: